AN UNBIASED VIEW OF MS-444

BACKGROUNDTriple-unfavorable breast most cancers (TNBC) is highly aggressive with an elevated metastatic incidence as compared to other breast cancer subtypes. Having said that, mainly because of the absence of clinically reputable biomarkers and targeted therapy in TNBC, results are suboptimal. Consequently, there is an urgent will need to compreh